RxDoctor Payments Data

Eva Kolb, DO

Child & Adolescent Psychiatry · Colorado Springs, CONPI 1750724951

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Vanda Pharmaceuticals Inc. at 28.9% of the total. Reporting peaked in 2022 at $542 and has fallen 95.4% since, to $25 in 2024.

$596in general payments, 2019–2025

Across 26 payments — averaging $22.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$172
  • Lundbeck LLC$86
  • Teva Pharmaceuticals USA, Inc.$82
  • Neurocrine Biosciences, Inc.$46
  • AbbVie$45
  • Sunovion Pharmaceuticals Inc.$43
  • plus $122 from 5 others

What the payments were for

  • Food & beverage$596100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$596 in reported general payments places this provider in the 85th percentile of 67 child & adolescent psychiatry providers in Colorado.

See all child & adolescent psychiatry providers in Colorado

Medicare billing

Part B allowed, 2024
$1,161
Medicare patients
11
Services billed
13

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxcarbazepine12$244
Olanzapine19$181
Sertraline Hcl12$74
Clonidine Hcl11$24

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →